INTERMEDIATE-ACTING INSULIN PREPARATIONS - NPH AND LENTE

被引：38
|
作者：
DECKERT, T
机构：
来源：
DIABETES CARE | 1980年 / 3卷 / 05期
关键词：
D O I：
10.2337/diacare.3.5.623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：623 / 626
页数：4
相关论文
共 50 条
  • [41] Oral nateglinide administration improves glycemic control of Type 2 diabetic patients, treated with intermediate-acting insulin
    Fujita, T
    Kosugi, K
    Ueda, N
    Hatano, M
    DIABETES, 2001, 50 : A435 - A435
  • [42] Time-action profiles of the intermediate-acting insulin analogue - Des(64,65)-human proinsulin
    Heinemann, L
    Heise, T
    Klepper, A
    Ampudia, J
    Bender, R
    Starke, AAR
    DIABETES & METABOLISM, 1995, 21 (06): : 415 - 419
  • [43] Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products
    Bullano, MF
    Al-Zakwani, IS
    Fisher, MD
    Menditto, L
    Willey, VJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (02) : 291 - 298
  • [44] SYNTHESIS AND BIOACTIVITY OF DES(64,65)-HUMAN PROINSULIN (D), A SOLUBLE, INTERMEDIATE-ACTING INSULIN AGONIST
    HOFFMANN, JA
    CHANCE, RE
    CUSICK, T
    RABE, CA
    TINSLEY, FC
    WILLIAMS, VK
    MYERS, SR
    DIABETES, 1993, 42 : A54 - A54
  • [45] Insulin Glargine Versus Intermediate-Acting Insulin as the Basal Component of Multiple Daily Injection Regimens for Adolescents with Type 1 Diabetes Mellitus
    Chase, H. Peter
    Arslanian, Silva
    White, Neil H.
    Tamborlane, William V.
    JOURNAL OF PEDIATRICS, 2008, 153 (04): : 547 - 553
  • [46] MISCIBILITY OF HUMAN SEMISYNTHETIC REGULAR AND LENTE INSULIN (ACTRAPID HUMAN MONOTARD HUMAN) AND HUMAN BIOSYNTHETIC REGULAR AND NPH INSULIN (HUMULIN REGULAR/NPH)
    OLSSON, PO
    ARNQVIST, H
    VONSCHENCK, H
    ACTA ENDOCRINOLOGICA, 1986, 112 : 41 - 41
  • [47] Postoperative residual block after intermediate-acting neuromuscular blocking drugs
    Hayes, AH
    Mirakhur, RK
    Breslin, DS
    Reid, JE
    McCourt, KC
    ANAESTHESIA, 2001, 56 (04) : 312 - 318
  • [48] TREATMENT OF TYPE-II DIABETES WITH HOMOLOGOUS INTERMEDIATE-ACTING COMBINATION INSULINS - COMPARISON OF THE EFFECTIVENESS OF 5 COMMONLY USED PREPARATIONS
    HAUPT, E
    HOPPE, FU
    RUDOLF, R
    BAMBERG, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (31-32) : 1209 - 1212
  • [49] Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study
    Fracassi, Federico
    Linari, Guido
    Del Baldo, Francesca
    Di Cunzolo, Antonella
    D'Angelo, Simona
    Malerba, Eleonora
    Carotenuto, Gaia
    Bonfanti, Ugo
    Corradini, Sara
    VETERINARY RECORD, 2018, 183 (08) : 262
  • [50] A NEW LONG-ACTING INSULIN - A PRELIMINARY TRIAL OF LENTE NOVO INSULIN
    LAWRENCE, RD
    OAKLEY, W
    BRITISH MEDICAL JOURNAL, 1953, 1 (4804): : 242 - 244
12345